
Muscle health is about more than how strong you feel—or how much muscle appears on a body-composition report.
The Myomar Muscle Health Test is a non-invasive, laboratory-analyzed urine test that measures a panel of molecular biomarkers related to muscle metabolism.
At Ontario Regenerative Medicine, Myomar results can be considered alongside your body composition, health history, physical activity, nutrition and other relevant information to provide another perspective on your muscle health.
Go beyond how much muscle you have. Learn more about what’s happening at the molecular level.
Myomar is a urine-based laboratory test designed to provide information about biomarkers associated with muscle metabolism.
The test involves collecting a urine sample that is analyzed by the Myomar laboratory.
Results are compiled into a personalized report that can be reviewed as part of your broader muscle-health assessment.
The test is:
Rather than viewing the result as a stand-alone diagnosis, ORM uses the information as one piece of a more complete muscle-health picture.
Different assessments tell us different things.
A body-composition assessment can estimate how much skeletal muscle you have and how lean mass is distributed throughout your body.
Functional assessment can provide information about how you move or perform.
Molecular biomarker testing provides a different type of information.
Myomar analyzes urine biomarkers associated with biological processes involving muscle metabolism.
These approaches don’t necessarily replace one another.
They can provide different pieces of information about muscle health.
The Myomar laboratory analyzes a proprietary panel of biomarkers associated with muscle metabolism.
According to Myomar, the panel includes biomarkers relating to areas such as:
The laboratory combines its biomarker measurements and analytical methodology to generate the patient’s Myomar Muscle Health Report.
Because the test uses a proprietary biomarker panel and algorithm, individual results should be interpreted according to the laboratory’s validated methodology and within the context of the individual patient.
Skeletal muscle isn’t static tissue.
Proteins within muscle are continuously being synthesized and broken down as part of normal physiology.
This ongoing process is referred to as muscle protein turnover.
Factors such as:
can influence muscle biology.
Myomar measures molecular biomarkers associated with these processes to provide additional information for consideration within a muscle-health assessment.
At ORM, we don’t believe one measurement tells the entire story.
InBody can provide estimates of measurements such as:
This helps answer:
“What does my body composition look like today?”
Myomar analyzes molecular biomarkers associated with muscle metabolism.
This provides a different type of information:
“What do these muscle-related molecular biomarkers show?”
The two assessments can therefore provide complementary information when clinically appropriate.
You may be interested in learning more about your muscle health if:
These circumstances don’t establish that something is wrong with your muscle.
They may simply be reasons to understand it better.
Changes in skeletal muscle can become increasingly relevant as we age.
Maintaining physical capacity involves more than simply watching body weight.
Understanding muscle mass, strength, function and other relevant measurements can provide useful information when considering long-term physical health.
Molecular biomarker information may add another perspective when it is appropriate for the individual.
The objective isn’t to find a problem.
It’s to better understand where you are today.
ORM provides your Myomar collection kit along with instructions for completing the test.
The kit contains the materials required to collect your urine sample.
You’ll collect your urine sample according to the instructions provided with the kit.
Because the test is urine-based, no blood draw is required.
You’ll also complete a digital questionnaire.
This provides additional information that can help place your laboratory results in context.
Your sample is returned to the Myomar laboratory using the provided materials and instructions.
The laboratory analyzes its proprietary panel of muscle-related molecular biomarkers.
The results are processed according to Myomar’s analytical methodology to generate your report.
Your results are compiled into a personalized Myomar Muscle Health Report.
Rather than simply looking at a score in isolation, the report can be reviewed within the broader context of your muscle health.
You can meet with the ORM team to discuss your report and what the findings may mean in the context of:
If additional assessment is appropriate, your provider can discuss the next steps with you.
The Myomar report may include a proprietary score derived from the laboratory’s biomarker analysis.
A score can make complex information easier to understand, but it shouldn’t be interpreted as a complete assessment of your muscle health by itself.
Your result should be considered alongside the underlying biomarker information and your broader clinical context.
One score isn’t the whole story.
Molecular biomarker testing is intended to provide information about biological processes that may not be apparent from body weight or appearance alone.
However, a Myomar result should not be treated as a stand-alone diagnosis of muscle loss, sarcopenia or another medical condition.
If your results raise a concern, additional assessment may be appropriate.
Not necessarily.
A laboratory test can provide information about the biomarkers it measures, but changes in muscle mass, strength or function can have many possible contributing factors.
These may include:
Your healthcare provider can consider the Myomar findings together with other information when determining whether further investigation is appropriate.
Myomar is a molecular urine test.
It should not be confused with a direct measurement or body-composition estimate of skeletal muscle mass.
At ORM, body-composition analysis can provide additional information about estimated skeletal muscle mass and lean-mass distribution.
That’s one reason the two approaches can be useful together.
No.
Muscle biomarkers, muscle mass and muscle strength are different measurements.
A molecular urine test does not replace appropriate assessment of physical strength or function when those measurements are relevant.
Depending on your individual goals and circumstances, repeat assessment may be considered.
Tracking results over time may provide information about changes in the measurements being evaluated.
However, changes should be interpreted carefully.
A change in a biomarker or score doesn’t automatically establish that a particular exercise program, diet, supplement or medical treatment caused the change.
Your provider can help place repeat results into context.
ORM can combine different forms of assessment when appropriate.
InBody
Helps estimate how much muscle you have and how it is distributed.
Myomar
Provides molecular biomarker information associated with muscle metabolism.
Your Health Assessment
Provides the context needed to understand why the information may matter.
Together, these can provide a broader view than relying on body weight alone.
ORM’s approach may consider several dimensions of muscle health:
Body Composition
How much estimated skeletal muscle and body fat contribute to your body composition?
Muscle Distribution
How is estimated lean mass distributed throughout your body?
Molecular Biomarkers
What information does your Myomar report provide about the biomarkers it measures?
Strength & Function
Have you noticed changes in your physical capacity or everyday activities?
Nutrition & Activity
What factors may be relevant to maintaining your muscle?
Medical Context
Are there health, medication, hormonal or other considerations that warrant further assessment?
The objective is not simply to produce more numbers.
It’s to make the numbers more meaningful.
Myomar is a laboratory-analyzed urine test that measures a proprietary panel of molecular biomarkers associated with muscle metabolism.
No.
The Myomar test uses a urine sample.
According to the current ORM program information, samples are analyzed by the Myomar laboratory in Sudbury.
The laboratory analyzes a proprietary panel of biomarkers associated with muscle metabolism and uses its methodology to generate a personalized report.
No.
InBody uses bioelectrical impedance analysis to estimate body composition.
Myomar analyzes molecular biomarkers in urine.
The tests provide different types of information.
The Myomar report should not be presented as a stand-alone diagnosis of sarcopenia.
Clinical concerns about sarcopenia require appropriate assessment of muscle strength, mass and physical function.
No.
Molecular biomarkers don’t directly measure muscle strength.
Repeat testing may be considered depending on your goals and circumstances.
Your ORM provider can discuss whether and when repeat assessment would provide useful information.
Myomar may provide information about changes in the biomarkers it measures.
However, muscle-health progress can involve several dimensions, including strength, physical function and body composition.
No single biomarker test should be used to determine the effectiveness of an exercise program in isolation.
Your report can be reviewed with ORM to help you understand the findings in the context of your overall muscle health.
If additional assessment or follow-up is appropriate, the ORM team can discuss your next steps.
You can see your body weight.
You can measure your body composition.
And now molecular testing can provide another type of information to consider when exploring your muscle health.
No single test tells the entire story.
That’s why ORM brings the information together.
Measure your muscle. Explore the biology. Understand the bigger picture.
The Myomar Muscle Health Test is a laboratory-analyzed urine test that measures molecular biomarkers associated with muscle metabolism.
Results should be interpreted according to the laboratory’s validated methodology and within the context of the individual.
The Myomar test should not be considered, by itself, a diagnosis of sarcopenia, muscle loss or another medical condition.
Changes in biomarkers or scores should not automatically be attributed to a particular treatment, diet, supplement or exercise intervention.
Appropriate medical or functional assessment may be recommended depending on individual results and circumstances.